A marathon for AGSD-UK
Angela Regazzoni is running the London Marathon on 22 April. Read more and sponsor her - click here.
AGSD-UK Annual Conference 2012 Bedfordshire

A date for your diary - Sat 29 and Sun 30 September. A fabulous location for a great weekend. More details.
Pilot drug trial in McArdle's
The MDC has announced a major grant for a pilot drug trial in McArdle Disease. You can read more about the grant here.

 

 

Glycogen Storage Disease Type V (McArdle Disease)

Also known as myophosphorylase deficiency.

McArdle disease is a rare metabolic disorder which causes muscle pain in everyday activities and exercise. If activity is prolonged despite the pain then muscle damage ensues with the risk of muscle breakdown and kidney failure.

Symptoms are usually apparent during the first decade of life but many people do not manage to obtain a diagnosis until the third or fourth decade. Later in life some people with McArdle disease experience fixed muscle weakness, possibly from cumulative muscle damage. It is important for those with McArdle disease to take regular aerobic exercise such as walking and avoid anaerobic activities such as lifting heavy weights.

Type V summary
Symptoms Muscle pain on everyday activity and exercise.
Fatigue. Fixed contractures with rhabdomyolysis.
Secondary symptoms Raised urate level. Possible muscle wasting.
Treatment No specific treatment. Maintain healthy diet,
control weight, take gentle aerobic exercise.
Outlook Good with gentle aerobic exercise and
avoidance of anaerobic activity.

 

Coordinator

The Coordinator for Type V is Andrew Wakelin. You can contact him via the Contact us page, or telephone him on 01597 860686.

 

 

  NEW Jen's Moonwalk Marathon Blog  

 

About the disease

 

Exercise and McArdle Disease

 

Background information